Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cypros acquires well-established Rx for esophageal varices

Nov. 15, 1996

Human pharmacokinetic/pharmacodynamic studies on bosentan

Nov. 15, 1996

NEP and ECE inhibitors reported by Kali-Chemie

Nov. 15, 1996

Clinical trials update on nibentan, Russian antiarrhythmic drug

Nov. 15, 1996

Chugai discloses antiischemic agents

Nov. 15, 1996

FDA approves once-daily antihypertensive combination

Nov. 15, 1996

Biovail licenses once-daily diltiazem

Nov. 15, 1996

Endothelin antagonists claimed by E. Merck

Nov. 15, 1996

Fujisawa describes ACE and/or NEP inhibitors

Nov. 15, 1996

Dual ACE/NEP inhibitors from Fujisawa

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...